IN8bio, Inc. (INAB)

IN8bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.12	21.28	18.18	37.02	17.99
Cash & Short-Term Investments	11.12	21.28	18.18	37.02	17.99
Cash Growth	-47.75%	17.05%	-50.89%	105.74%	2849.84%
Prepaid Expenses	1.16	3.07	3.82	1.91	0.15
Other Current Assets	0.3	0.27	0.23	0.05	-
Total Current Assets	12.58	24.63	22.23	38.98	18.14
Property, Plant & Equipment	7.83	8.57	10.3	2.83	0.19
Long-Term Deferred Charges	-	-	-	-	2.44
Other Long-Term Assets	0.54	0.51	0.51	0.41	0.14
Total Assets	20.94	33.71	33.04	42.22	20.91
Accounts Payable	0.39	0.92	2.09	0.4	0.62
Accrued Expenses	1.05	2.96	2.34	1.24	0.9
Current Portion of Long-Term Debt	-	-	-	-	0.17
Current Portion of Leases	1.65	1.51	1.39	0.63	-
Other Current Liabilities	-	-	-	-	0.88
Total Current Liabilities	3.08	5.39	5.82	2.26	2.57
Long-Term Leases	3.38	3.38	4.49	1.78	-
Long-Term Unearned Revenue	-	-	-	-	0.02
Total Liabilities	6.47	8.77	10.31	4.04	2.59
Common Stock	0.01	0	0	0	0
Additional Paid-In Capital	136.13	116.15	83.94	70.87	1.46
Retained Earnings	-121.66	-91.22	-61.21	-32.69	-18.04
Total Common Equity	14.48	24.94	22.73	38.18	-16.58
Shareholders' Equity	14.48	24.94	22.73	38.18	18.32
Total Liabilities & Equity	20.94	33.71	33.04	42.22	20.91
Total Debt	5.03	4.89	5.87	2.41	0.17
Net Cash (Debt)	6.09	16.39	12.31	34.61	17.82
Net Cash Growth	-62.84%	33.16%	-64.44%	94.23%	2821.31%
Net Cash Per Share	0.11	0.55	0.59	3.47	5.21
Filing Date Shares Outstanding	81.26	43.29	24.94	18.81	3.76
Total Common Shares Outstanding	72.48	43.29	24.55	18.78	3.76
Working Capital	9.5	19.23	16.41	36.72	15.57
Book Value Per Share	0.20	0.58	0.93	2.03	-4.40
Tangible Book Value	14.48	24.94	22.73	38.18	-16.58
Tangible Book Value Per Share	0.20	0.58	0.93	2.03	-4.40
Machinery	0.85	0.75	0.69	0.44	0.44
Construction In Progress	-	0.18	0.03	0.4	-
Leasehold Improvements	3.92	3.92	3.9	-	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q